Blood pressure and heart rate effects of prostaglandin E2 and F2 alpha produced by intracerebroventricular injections in cats

Prostaglandins
R A GillisP W Ramwell

Abstract

Blood pressure and heart rate effects of prostaglandin E2 and F2 alpha were examined after administering each agent into the left lateral brain ventricle of chloralose-anesthetized cats. Administration of prostaglandin E2 (1 micrograms) resulted in significant, prolonged increases in arterial pressure (25.7 +/- 6.7 mm Hg) and heart rate (19.4 +/- 07.7 beats/min). These responses were mimicked when the same dose of prostaglandin E2 was administered into and restricted to the lateral and third ventricles via cannulation of the cerebral aqueduct, whereas no significant cardiovascular responses occurred with administration into the fourth ventricle. Intravenous injection of prostaglandin E2 resulted in a transient decrease in blood pressure but no change in heart rate. Administration of prostaglandin F2 alpha (1 and 3 micrograms) into the CNS produced no significant cardiovascular responses. The same was true when prostaglandin F2 alpha was administered by the intravenous route. These results indicate that pronounced cardiovascular effects can be produced by administering prostaglandin E2 but not F2 alpha into the CNS, and that the central site of action of prostaglandin E2 is in the forebrain.

References

Jan 1, 1979·Annual Review of Physiology·L S Wolfe, F Coceani
Jan 1, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·A Walland
Jan 1, 1975·Progress in Neurobiology·F R CalaresuG J Mogenson
Nov 1, 1977·Stroke; a Journal of Cerebral Circulation·A A HagenJ T Robertson
Mar 1, 1976·Prostaglandins·D J Rinchuse, R R Deuben
Jan 1, 1969·International Journal of Neuropharmacology·H R KaplanJ P Buckley
Feb 1, 1973·Proceedings of the Society for Experimental Biology and Medicine·E A GyangJ P Buckley
Sep 1, 1974·Journal of Neurosurgery·E La TorreD Grossi-Belloni
Jul 1, 1970·British Journal of Pharmacology·H A LaveryG C Scroop

❮ Previous
Next ❯

Citations

Jan 28, 1983·European Journal of Pharmacology·E K Chiu, J S Richardson
Jan 1, 1983·General Pharmacology·E K Chiu, J S Richardson
Nov 1, 1988·Journal of Clinical Pharmacology·L J LipkaJ Roberts
Nov 1, 1982·Circulation Research·E F EllisH A Kontos
Feb 10, 2021·Canadian Journal of Physiology and Pharmacology·Niketa SareenSanjiv Dhingra

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.